GET THE APP

Secondary Cutaneous Myeloid Sarcoma Treated with Nanoliposomal Encapsulation of Daunorubicin and Cytarabine

Clinical Oncology: Case Reports.

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Secondary Cutaneous Myeloid Sarcoma Treated with Nanoliposomal Encapsulation of Daunorubicin and Cytarabine

Cutaneous myeloid sarcoma is a rare malignancy and most often arises in the setting of acute myeloid leukemia. Here, we present the unique case of a patient who developed secondary cutaneous myeloid sarcoma after developing myelodysplastic syndrome from breast cancer treatment. We describe complete resolution of her lesions after treatment with a nanoliposomal dual encapsulation of daunorubicin and cytarabine and to our knowledge the first known treatment of a patient with cutaneous myeloid sarcoma with this regimen.

Special Features

Full Text

View

Track Your Manuscript

Media Partners

Associations